Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 in Healthy Adult Subjects

The purpose of this study is to compare the pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Inclusion Criteria:

• healthy adult subjects who signed informed consent

Exclusion Criteria:

• Subjects has a history of allergy reaction of study drug ingredient
• Subjects participated in another clinical trial within 6 months prior to administration of the study drug
• Inadequate subject for the clinical trial by the investigator's decision